BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
cell-cell adhesion
,
Pseudomonas infection
,
Neuron
,
Laryngoscope
,
Trichostatin A
,
MYC
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
BCR/ABL fusion
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
The Body Atlas is only available for genes, tissues, biosources and biogroups.
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
There were no matches for BCR/ABL fusion
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
There were no matches for BCR/ABL fusion
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
There were no matches for BCR/ABL fusion
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Chronic myeloid leukemias with BCR-ABL fusions before and after imatinib mesylate treatment
BCR-ABL positive Adult Acute Lymphoblastic Leukemia
LSK bone marrow cells tranformed with combinations of BCR-ABL and NUP98-HOXA9
Effects of BCR-ABL expression in long-term repopulating hematopoietic stem cells
Spleens of mice transplanted with stem cells expressing fusion proteins BCR/ABL and ABL/BCR
Explore Curated Studies Results
Literature
Most Relevant Literature
BCR-ABL prevents c-jun-mediated and proteasome-dependent FUS (TLS) proteolysis through a protein kin…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Study to Evaluate Tolerability, Safety, Pharmacokinetics and Preliminary Efficacy of PF-114 for Oral…
Phase II Front-line Ponatinib in Adult Philadelphia+/BCR-ABL+ Acute Lymphoblastic Leukemia.
Homoharringtonine (Omacetaxine Mepesuccinate) in Treating Patients With Chronic Myeloid Leukemia (CM…
Blinatumomab, Methotrexate, Cytarabine, and Ponatinib in Treating Patients With Philadelphia Chromos…
Combination Chemotherapy and Dasatinib in Treating Participants With Philadelphia Positive or BCR-AB…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ